Abstract
Adiponectin (ADPN) counteracts the inflammatory response of the endothelium, which plays an important role in the development of atherosclerosis in patients with chronic kidney disease (CKD). Data in children with CKD are scarce. We examined serum ADPN concentration in 90 children with various renal disorders: 28 with CKD on conservative treatment (CKD), 21 on regular dialysis treatment (D), and 41 after kidney transplantation (Tx); 27 age-matched healthy children served as controls (C). Body mass index (BMI), estimated glomerular filtration rate (eGFR), lipids, homocysteine, high sensitivity CRP (hsCRP), and systolic blood pressure (SBP) were also measured. Mean serum ADPN concentration was significantly higher in patients with CKD (27.3 μg/ml ±15.0), on D (34.2 μg/ml ±14.9), and after Tx (23.6 μg/ml ±9.5) compared with ADPN levels in C (13.5 μg/ml ±6.1) (p < 0.0001). Serum ADPN concentration was inversely related to BMI (p = 0.001) and SBP (p = 0.004). In the multiple linear regression analysis, only SBP remained independently associated with ADPN plasma levels. Data show that children with CKD have significantly higher serum ADPN, even after Tx. The protective antiarthrosclerotic effect of ADPN may be mediated by lower SBP, a finding that deserves further study.
Similar content being viewed by others
References
Wheeler DC (1996) Cardiovascular disease in patients with chronic renal failure. Lancet 348:1673–1674
Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105
Foley RN, Parfrey SP, Sarnak MJ (1998) Cardiovascular disease in chronic renal failure. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 32(Suppl 3):112–119
Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22–27
Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau V (1990) Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86:228–234
Farid FA, Faheem MS, Heshmat NM, Shaheen KY, Saad SS (2004) Study of the homocysteine status in children with chronic renal failure. Am J Nephrol 24:289–295
Kari JA, Donald AE, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bruce T (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468–472
Querfeld U (2004) The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol 19:478–484
Bilginer Y, Ozaltin F, Basaran C, Aki TF, Karabulut E, Duzova A, Besbas N, Topaloglu R, Ozen S, Bakkaloglu M, Bakkaloglu A (2007) Carotid intima-media thickness in children and young adults with renal transplant: internal carotid artery vs. common carotid artery. Pediatr Transplant 11:888–894
Flynn JT (2006) Cardiovascular disease in children with chronic renal failure. Growth Horm IGF Res 16(Suppl A):S84–S90
Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahshi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473–2476
Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296–1301
Wiecek A, Kokot F, Cudek J, Adamczak M (2002) The adipose tissue – a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 17:191–195
Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (2002) Adipocyte-derives plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105:2893–2898
Fesüs G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC, Gollasch M (2007) Adiponectin is a novel humoral vasodilator. Cardiovasc Res 75:719–727
Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ (2003) Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021–45026
Zoccali C, Mallamaci F, Tripepi G, Benedetto F, Cutrupi S, Parlongo S, Malatino L, Bonanno G, Seminara S, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134–141
Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T (2004) Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43:1318–1323
Adamczak M, Chudek J, Wiecek A (2009) Adiponectin in patients with chronic kidney disease. Semin Dial 22(4):391–395
Bakkaloglu SA, Buyan N, Funahashi T, Pasaoglu H, Elhan AH, Hasanoglu E, Soylemezoglu O (2005) Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients. Perit Dial Int 25:357–361
Bakkaloglu SA, Soylemezoglu O, Buyan N, Oktar SO, Funahashi T, Pasaoglu H, Elhan AH, Peru H, Hasanoglu E (2006) Adiponectin levels and arteriosclerotic risk factors in pediatric renal transplant recipients. Pediatr Transplant 10:187–192
Mitsnefes M, Kartal J, Khoury P, Daniels S (2007) Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction. Clin J Am Soc Nephrol 2:46–50
Arbeiter AK, Büscher R, Petersenn S, Hauffa BP, Mann K, Hoyer PF (2009) Ghrelin and other appetite-regulation hormones in pediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 24:643–646
Büscher AK, Büscher R, Hauffa BP, Hoyer PF (2010) Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease. Pediatr Nephrol 25:2295–2301
Kamariski M, Biscardi M, Cestino L, Miatello R, Guntsche E, Valles PG (2009) Adiponectin in children on peritoneal dialysis: relationship to insulin resistance and nutritional status. Nephron Clin Pract 113:c24–c32
Iwashima A, Horio T, Kumada M (2006) Adiponectin and renal function, and implication as a risk of cardiocaskular disease. Am J Cardiol 98(12):1603–1608
Shoji T, Kimoto E, Shinohara K, Hatsuda S, Nishizawa Y (2004) Molecular forms of adiponectin in uremic plasma (Letter to the editor). Nephrol Dial Transplant 19:1938
Shen YY, Charlesworth JA, Kelly JJ, Peake PW (2007) The effect of renal transplantation on adiponectin and its isoforms and receptors. Metabolism 56:1201–1208
Punthakee Z, Delvin EE, O'loughlin J, Paradis G, Levy E, Platt RW, Lambert M (2006) Adiponectin, adiposity and insulin resitance in children and adolescents. J Clin Endocrinol Metab 91(6):2119–2125
Guebre-Egziabher F, Bernhard J, Funahashi T (2005) Adiponectin in chronic kidney disease is related more to metabolic disturbance than to decline in renal function. Nephrol Dial Transplant 20(1):129–134
Schoppen S, Riestra P, García-Anguita A, López-Simón L, Cano B, de Oya I, de Oya M, Garcés C (2010) Leptin and adiponectin levels in pubertal children: relationship with anthropometric variables and body composition. Clin Chem Lab Med 48(5):707–711
Sethna CB, Leonard MB, Gallagher PR, Meyers KE (2009) Serum adiponectin levels and ambulatory blood pressure monitoring in pediatric renal transplant recipients. Transplantation 88(8):1030–1037
Agata J, Nagahra D, Kinoshita S, Takagawa Y, Moniwa N, Yoshida D, Ura N, Shimamoto K (2004) Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J 68(12):1194–119834
Ouchi N, Kihara S, Funashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107:671–674
Acknowledgements
We gratefully acknowledge the assistance of Mrs. Westphal, technician in the laboratory of the Children’s Hospital of the University of Hamburg.
Author information
Authors and Affiliations
Corresponding author
Additional information
M.J. Kemper and D.E. Müller-Wiefel contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Möller, K.F., Dieterman, C., Herich, L. et al. High serum adiponectin concentration in children with chronic kidney disease. Pediatr Nephrol 27, 243–249 (2012). https://doi.org/10.1007/s00467-011-1971-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-011-1971-1